Weill Cornell Medical College, Doha, State of Qatar, Qatar.
J Clin Immunol. 2013 Feb;33(2):317-24. doi: 10.1007/s10875-012-9812-y. Epub 2012 Oct 3.
Primary immunodeficiency diseases (PID) are a group of heterogeneous, rare, genetic, mainly childhood disorders that affect specific components of immune system leading to serious complications.
This study is aimed at describing the prevalence and the categories of PID, the ages of onset and the diagnosis, the clinical presentations, the treatment modalities and the overall outcome of affected patients.
A retrospective study was conducted on 131 pediatric patients (aged 0-14 years) diagnosed with PID at Hamad General Hospital during a 15-year period (1998-2012).
Data of 131 patients (75 males & 56 females) was analyzed with an estimated prevalence of 4.7 PID patients per 100,000 children younger than 14 years of age. The most common type of PID was predominantly antibody deficiency (23.7 %), followed by other well-defined immunodeficiency syndromes (22.9 %), 19.1 % combined T and B cell immunodeficiency, but rare CVID, and no cases of complement deficiency. The mean onset age was 24.01 months and diagnosis age was 42.2 months. Recurrent infections, particularly pneumonia (48.9 %), failure to thrive (34.4 %), otitis media (26 %), sepsis (23.7 %), and chronic diarrhoea (21.4 %) were commonest presenting conditions. P. aeruginosa (15.7 %), Salmonella species (13.2 %), and Non-TB mycobacteria (13.2 %) were the most common bacterial isolates. The overall mortality rate was 21.4 % with combined immunodeficiency's accounting for 53.4 % of deaths.
This study reveals that PIDs are not rare in children in Qatar; and like other studies predominantly antibody deficiencies are the most common. Strategies that reinforce awareness and education of practicing physicians, bone marrow transplantation, and establishing PID national registry should be adopted to reduce mortality and morbidity of PID patients in Qatar.
原发性免疫缺陷病(PID)是一组异质性、罕见的遗传性疾病,主要发生于儿童,影响免疫系统的特定成分,导致严重并发症。
本研究旨在描述 PID 的流行率和分类、发病年龄和诊断、临床表现、治疗方式以及患者的总体预后。
对哈马德总医院 15 年间(1998 年至 2012 年)诊断为 PID 的 131 例儿科患者(0-14 岁)进行回顾性研究。
对 131 例患者(75 例男性和 56 例女性)的数据进行了分析,估计 14 岁以下儿童每 10 万人中有 4.7 例 PID。最常见的 PID 类型是主要抗体缺陷(23.7%),其次是其他明确的免疫缺陷综合征(22.9%)、19.1%的 T 和 B 细胞联合免疫缺陷,但罕见的 CVID,且无补体缺陷病例。平均发病年龄为 24.01 个月,诊断年龄为 42.2 个月。反复感染,特别是肺炎(48.9%)、生长发育迟缓(34.4%)、中耳炎(26%)、败血症(23.7%)和慢性腹泻(21.4%)是最常见的首发症状。最常见的细菌分离株是铜绿假单胞菌(15.7%)、沙门氏菌(13.2%)和非结核分枝杆菌(13.2%)。总死亡率为 21.4%,其中联合免疫缺陷占死亡人数的 53.4%。
本研究表明,PID 在卡塔尔儿童中并不罕见;与其他研究一样,主要的抗体缺陷是最常见的。应采取强化执业医师意识和教育、骨髓移植以及建立 PID 国家登记册等策略,以降低卡塔尔 PID 患者的死亡率和发病率。